−0.8720USD
−114.33 MUSD
46.74 MUSD
102.88 M
About Scilex Holding Company
Sector
CEO
Jaisim Shah
Headquarters
Palo Alto
Website
Employees (FY)
105
Founded
2020
FIGI
BBG00YJTT4L8
Scilex Holding Co. engages in the acquisition, development, and commercialization of non-opioid pain management products for the treatment of acute and chronic pain. Its products include ZTlido, a prescription lidocaine topical product approved by the FDA for the relief of neuropathic pain associated with PHN, which is a form of post-shingles nerve pain, and e GLOPERBA oral solutions, an FDA-approved prophylactic treatment for painful gout flares in adults. The company was founded on February 21, 2020 and is headquartered in Palo Alto, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SCLX is 0.8500 USD — it has decreased by 12.97% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Scilex Holding Company stocks are traded under the ticker SCLX.
Scilex Holding Company is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
SCLX stock is 17.67% volatile and has beta coefficient of 2.30. Check out the list of the most volatile stocks — is Scilex Holding Company there?
SCLX earnings for the last quarter are −0.63 USD per share, whereas the estimation was −0.33 USD resulting in a −92.86% surprise. The estimated earnings for the next quarter are −0.23 USD per share. See more details about Scilex Holding Company earnings.
Scilex Holding Company revenue for the last quarter amounts to 10.11 M USD despite the estimated figure of 11.37 M USD. In the next quarter revenue is expected to reach 11.43 M USD.
Yes, you can track Scilex Holding Company financials in yearly and quarterly reports right on TradingView.
SCLX stock has fallen by 27.97% compared to the previous week, the month change is a 40.56% fall, over the last year Scilex Holding Company has showed a 87.59% decrease.
SCLX net income for the last quarter is −21.40 M USD, while the quarter before that showed −35.53 M USD of net income which accounts for 39.77% change. Track more Scilex Holding Company financial stats to get the full picture.
Today Scilex Holding Company has the market capitalization of 162.32 M, it has decreased by 17.98% over the last week.
No, SCLX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, SCLX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Scilex Holding Company stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 25, 2024, the company has 105.00 employees. See our rating of the largest employees — is Scilex Holding Company on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Scilex Holding Company technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Scilex Holding Company stock shows the strong sell signal. See more of Scilex Holding Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Scilex Holding Company future price: according to them, SCLX price has a max estimate of 12.00 USD and a min estimate of 4.00 USD. Read a more detailed Scilex Holding Company forecast: see what analysts think of Scilex Holding Company and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Scilex Holding Company EBITDA is −100.96 M USD, and current EBITDA margin is −216.68%. See more stats in Scilex Holding Company financial statements.